ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information

Li, Xin; Zhang, Xuan; Lin, Xiangyu; Cai, Liting; Wang, Yan*; Chang, Zhiqiang*哈尔滨医科大学; 1; y
Genes2022-10DOI: 10.3390/genes13101913
5被引6阅读
引用收藏
分享

摘要

Pancreatic adenocarcinoma (PAAD) has a poor prognosis with high individual variation in the treatment response among patients; however, there is no standard molecular typing method for PAAD prognosis in clinical practice. We analyzed DNA methylation data from The Cancer Genome Atlas database, which identified 1235 differentially methylated DNA genes between PAAD and adjacent tissue samples. Among these, 78 methylation markers independently affecting PAAD prognosis were identified after adjusting for significant clinical factors. Based on these genes, two subtypes of PAAD were identified through consistent clustering. Fourteen specifically methylated genes were further identified to be associated with survival. Further analyses of the transcriptome data identified 301 differentially expressed cancer driver genes between the two PAAD subtypes and the degree of immune cell infiltration differed significantly between the subtypes. The 14 specific genes characterizing the unique methylation patterns of the subtypes were used to construct a Bayesian network-based prognostic prediction model for typing that showed good predictive value (area under the curve value of 0.937). This study provides new insight into the heterogeneity of pancreatic tumors from an epigenetic perspective, offering new strategies and targets for personalized treatment plan evaluation and precision medicine for patients with PAAD.

学科与关键词

关键词
pancreatic adenocarcinomaDNA methylationprognosisconsistency clusteringtumor classification
相关
加载中…
  • Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value
    Cao, Tiansheng*; Wu, Hongsheng; Ji, Tengfei*Frontiers in Pharmacology, 2023, 14: 1086309.
  • A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
    Xiao, Mingjia; Liang, Xiangjing; Yan, Zhengming; Chen, Jingyang; Zhu, Yaru; Xie, Yuan; Li, Yang; Li, Xinming; Gao, Qingxiang; Feng, Feiling*; Fu, Gongbo*; Gao, Yi*Frontiers in Immunology, 2022, 13: 803962.被引 13
  • Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma
    Liao, Hongying; Luo, Xiaolong; Huang, Yisheng; Yang, Xingping; Zheng, Yuzhen; Qin, Xianyu; Tan, Jian; Shen, Piao; Tian, Renjiang; Cai, Weijie; Shi, Xiaoshun*; Deng, Xiaofang*DISEASE MARKERS, 2022, 2022: 9389372.
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes
发表日期
2022-10
卷期
第 13 卷, 第 10 期
页码
1913
DOI
10.3390/genes13101913
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Haiyan Foundation of Harbin Medical University Cancer Hospital [JJMS2021-18]; Beijing Medical Award Foundation [YXJL-2020-1191-0237]

作者

  • L

    Li, Xin (第一作者)

    harbin med univ

  • Z

    Zhang, Xuan

    harbin med univ

查看全部 6 位作者收起作者
  • L

    Lin, Xiangyu

    harbin inst technol

  • C

    Cai, Liting

    1 · baotou med coll

  • W

    Wang, Yan (通讯)

    harbin med univ

  • C

    Chang, Zhiqiang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417